GB9214871D0 - Vaccines - Google Patents

Vaccines

Info

Publication number
GB9214871D0
GB9214871D0 GB929214871A GB9214871A GB9214871D0 GB 9214871 D0 GB9214871 D0 GB 9214871D0 GB 929214871 A GB929214871 A GB 929214871A GB 9214871 A GB9214871 A GB 9214871A GB 9214871 D0 GB9214871 D0 GB 9214871D0
Authority
GB
United Kingdom
Prior art keywords
vaccines
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GB929214871A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Medical Research Council
Original Assignee
Medical Research Council
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medical Research Council filed Critical Medical Research Council
Priority to GB929214871A priority Critical patent/GB9214871D0/en
Publication of GB9214871D0 publication Critical patent/GB9214871D0/en
Priority to JP6503132A priority patent/JPH07508984A/en
Priority to PCT/GB1993/001459 priority patent/WO1994001130A1/en
Priority to EP93916056A priority patent/EP0650369A1/en
Priority to AU45762/93A priority patent/AU4576293A/en
Priority to CA002140150A priority patent/CA2140150A1/en
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/70539—MHC-molecules, e.g. HLA-molecules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
GB929214871A 1992-07-13 1992-07-13 Vaccines Pending GB9214871D0 (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
GB929214871A GB9214871D0 (en) 1992-07-13 1992-07-13 Vaccines
JP6503132A JPH07508984A (en) 1992-07-13 1993-07-13 MHC antigen used as vaccine against immunodeficiency virus
PCT/GB1993/001459 WO1994001130A1 (en) 1992-07-13 1993-07-13 A major histocompatibility complex antigen for use as vaccine against an immunodeficiency virus
EP93916056A EP0650369A1 (en) 1992-07-13 1993-07-13 Major histocompatibility complex antigens for use as vaccine against an immunodeficiency virus
AU45762/93A AU4576293A (en) 1992-07-13 1993-07-13 A major histocompatibility complex antigen for use as vaccine against an immunodeficiency virus
CA002140150A CA2140150A1 (en) 1992-07-13 1993-07-13 A major histocompatibility complex antigen for use as vaccine against an immunodeficiency virus

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB929214871A GB9214871D0 (en) 1992-07-13 1992-07-13 Vaccines

Publications (1)

Publication Number Publication Date
GB9214871D0 true GB9214871D0 (en) 1992-08-26

Family

ID=10718631

Family Applications (1)

Application Number Title Priority Date Filing Date
GB929214871A Pending GB9214871D0 (en) 1992-07-13 1992-07-13 Vaccines

Country Status (6)

Country Link
EP (1) EP0650369A1 (en)
JP (1) JPH07508984A (en)
AU (1) AU4576293A (en)
CA (1) CA2140150A1 (en)
GB (1) GB9214871D0 (en)
WO (1) WO1994001130A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1274592B (en) * 1994-08-05 1997-07-18 Angela Turiano PHARMACEUTICAL COMPOSITION FOR CANCER THERAPY CONTAINING XENOANTIGENS
FR2735984B1 (en) * 1995-06-30 1997-09-19 Inst Nat Sante Rech Med VACCINE AGAINST INFECTIOUS AGENTS HAVING AN INTRACELLULAR PHASE, COMPOSITION FOR THE TREATMENT AND PREVENTION OF HIV INFECTIONS, ANTIBODIES AND DIAGNOSTIC METHOD
EP1000628A1 (en) * 1998-09-28 2000-05-17 Fondation Mondiale Recherche et Prevention SIDA Use of antigenic complexes of HIV envelope and HLA class I antigens as HIV vaccine
AU2005202644B2 (en) * 1999-06-01 2009-03-05 Janssen Alzheimer Immunotherapy Prevention and treatment of amyloidogenic disease

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991016924A1 (en) * 1990-05-10 1991-11-14 The Dana-Farber Cancer Institute Enhancing the association of exogenous peptides with class i mhc molecules on immune system cells

Also Published As

Publication number Publication date
JPH07508984A (en) 1995-10-05
EP0650369A1 (en) 1995-05-03
CA2140150A1 (en) 1994-01-20
WO1994001130A1 (en) 1994-01-20
AU4576293A (en) 1994-01-31

Similar Documents

Publication Publication Date Title
AP9300541A0 (en) Vaccines
AP9300530A0 (en) Vaccines
ZA947828B (en) Vaccines
IL99899A0 (en) Vaccines
GB9325496D0 (en) Vaccines
GB9215233D0 (en) Vaccines
GB9213559D0 (en) Vaccines
GB9214871D0 (en) Vaccines
GB9201023D0 (en) Vaccines
GB9322702D0 (en) Vaccines
ZA93919B (en) Vaccines
ZA948729B (en) Vaccines
GB9226768D0 (en) Vaccines
ZA933541B (en) Vaccines
GB9218833D0 (en) Vaccines
GB9221891D0 (en) Vaccines
GB9220360D0 (en) Vaccines
GB9226283D0 (en) Vaccines
GB9217635D0 (en) Vaccines
ZA935281B (en) Vaccines
GB9216317D0 (en) Vaccines
GB9211318D0 (en) Vaccines
GB9222156D0 (en) Vaccine
GB9206789D0 (en) Vaccine
GB9206786D0 (en) Vaccine